The Otsuka Group was established in 1921 by Mr. Busaburo Otsuka in Naruto, Tokushima Prefecture in Japan. They built a strong reputation in the area of intravenous solutions which was widely used in hospitals all over Japan.
In 1964, Otsuka Pharmaceutical Co., Ltd. (OPC) was founded. A sales company at first, the company soon established its own factory in 1970.
With the objective of developing new pharmaceutical products, Otsuka set up its own R & D the following year.
Akihiko Otsuka, in his determination to go global by 1980 gave the laboratory an English motto: ‘80 World Famous Otsuka. From the beginning, the company had its sights to make its presence recognized in the global market.
The vision became a reality. Otsuka today is a worldwide business expanding in the United States, Europe and all over Asia including the Philippines.
The Need to Go Beyond LDL-C Reduction in Managing Atherosclerosis
The last two decades have seen the rise of statins from obscurity to being one of the most prescribed medications worldwide in the management cardiovascular disease. In fact, the introduction of statins has significantly shared the current guidelines on lipid management that many clinicians follow today. Despite the significant reduction in low-density lipoprotein cholesterol (LDL-C) achieved by sensitive statin therapy, many patients are still at risk of developing cardiovascular disease
Dr. William Torres, President of UST CeDRES and Head Investigator of the study concluded that the generic test drug Cilostazol Clazol 100 mg tablet is not bioequivalent to the reference/innovator drug product, Pletaal 100mg.
There are innovator molecules and there are generic alternatives. The innovator is the original molecule developed by the company that discovered it. Upon expiration of its patent, the generic alternatives come in. Over the years we have developed a certain level of trust in using the original brand because the companies that market these have provided us with clinical data on efficacy and safety for its indicated treatment. We cannot say the same for all generic alternatives.d
It's 3:00 pm and you get out of your office for a quick stretching and walking. Then, you suddenly feel pain in your thigh and numbness in the leg as you walk, but the symptoms ease during rest. You may not worry about it, but these could be symptoms of Peripheral Arterial Disease (PAD).
PAD, a condition that is especially prevalent among those with diabetes, refers to the partial or complete blockage of major arteries outside the heart that supply blood to other important areas of the body, such as the brain, kidneys, arms and legs.
Symptoms include pain in the calf or thigh, discomfort, fatigue, and numbness in the legs when walking then eases during rest. One of the most common symptoms of PAD is intermittent claudication (IC). Patients with IC feel numbness and fatigue in the legs and this may affect their walking distance.
In addition to diet and exercise, drugs are prescribed to relieve symptoms of PAD and prevent further complications. Cilostazol is one of the drugs recommended to treat IC as it allows patients to increase their walking distance. In a study comparing the effects of cilostazol and placebo (sugar pill) on walking distance, the maximal walking distance of cilostazol patients improved by 44 to 50 percent compared to a 21-percent improvement achieved by patients taking placebo.
The Otsuka Group is constantly working to help improve the health and quality of life of people all over the world, consistent with our corporate philosophy “Otsuka – people creating new products for better health worldwide”. We at Otsuka (Philippines) Pharmaceuticals, Inc (OPPI), an affiliate of Otsuka Pharmaceuticals Corporation Japan, is committed to provide the best researched products, both pharmaceutical and nutraceutical and be a partner with the Filipino patients and healthcare professionals.
In 1997, OPPI was established with the aim of becoming a global value-creating company that can make a difference in the healthcare of Filipinos. By introducing products that will help cure illnesses, improve and sustain everyday health, OPPI seeks to contribute to the attainment of a richer, healthier livelihood for Filipinos and in improving its quality of life. Otsuka Philippines has come a long way and ready to face the next decade with renewed vigor, enthusiasm and pride. All this would not be possible without the dedication of our employees.
We promise to continue providing not only health products but at the same time contribute to the welfare of Filipinos through Otsuka Cares - our social responsibility group. You can expect that in the coming years there will be a continuation of the transformation process oriented towards increasing our innovative capability, improving operational efficiency and customer intimacy. That’s how we set ourselves apart from the others and facilitate a faster growth than the market.
It is our sincerest hope that this website will help you establish a rich and healthy livelihood; and in doing so, we are also hopeful that you can deepen your understanding about our company's business activities.
The December 16, 2011
Donations to Typhoon Sendong Victims read more >>
.gif){kind=small}
| About Us